Apoptosis is initiated by
**Core Concept**
Apoptosis, also known as programmed cell death, is a vital physiological process that eliminates damaged or unwanted cells from the body. It is a highly regulated process that involves a series of molecular events leading to the controlled destruction of cells.
**Why the Correct Answer is Right**
Apoptosis is initiated by the activation of caspases, a family of cysteine-aspartic acid proteases that play a central role in the execution phase of cell death. The mitochondrial pathway of apoptosis is initiated by the release of cytochrome c from the mitochondria, which binds to Apaf-1 and activates caspase-9. This leads to the activation of downstream caspases, including caspase-3, which executes the cell death program. The intrinsic pathway of apoptosis is triggered by various cellular stresses, including DNA damage, oxidative stress, and loss of survival signals.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because apoptosis is not initiated by the activation of protein kinase C (PKC). While PKC can regulate various cellular processes, it is not directly involved in the initiation of apoptosis.
**Option B:** This option is incorrect because the release of cytochrome c from the mitochondria is a key event in the initiation of apoptosis, but it is not the sole initiator. Other factors, such as DNA damage and loss of survival signals, can also trigger apoptosis.
**Option C:** This option is incorrect because the Bcl-2 family of proteins, while involved in regulating apoptosis, is not the primary initiator of apoptosis. Bcl-2 can inhibit apoptosis by blocking the release of cytochrome c, while pro-apoptotic members of the family, such as Bax and Bak, can promote apoptosis.
**Clinical Pearl / High-Yield Fact**
The mitochondrial pathway of apoptosis is a critical regulator of cell death in various diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. Understanding the molecular mechanisms of apoptosis is essential for developing targeted therapies for these conditions.
**Correct Answer:** C.